Aurora Cannabis (TSX:ACB) vs. Canopy Growth (TSX:WEED): Which Company Had the Better Quarter?

As the marijuana industry continues to evolve in Canada, it is important to keep track of who holds the upper hand in this competitive market. Of course, it isn’t just a matter of keeping score, as interesting as that may be. More importantly, though, given the exponential growth we are seeing unfold before our eyes, keeping track of important figures and metrics could literally pay rich dividends in the long run. Let’s turn our attention to how Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canopy Growth (TSX:WEED)(NYSE:CGC) — the two most prominent Canada-based pot companies — fared during their latest recorded quarters.

Revenues

Obviously, one of the most important numbers to look at when comparing these two pot giants is the revenues they were able to rack up during their respective quarters. Revenues have been improving at an extremely fast pace in the global marijuana market, and both Aurora and Canopy are grabbing their share of the pie. In this department, however, Canopy still has the upper hand over Aurora, posting revenues of $94.1 million, which was much higher than its competitor’s $65.1 million.

In particular, Canopy’s recreational sales were a whopping $68.9, a 100% growth year over year. Aurora’s recreational sales were much lower at $29.6 million. But Aurora has the upper hand when it comes to medical sales, with gross sales coming in at $29.1 million in this segment compared to $13.4 million for Canopy. It is essential to note that Canopy’s medical marijuana sales decreased somewhat substantially year over year.

Note that Canopy sold 9,326 kilograms of cannabis during its last quarter for an average price per gram cannabis of cannabis $7.49. Aurora sold slightly less at about 9,160 kilograms at an average price per gram of $6.40.

Gross profits

It is important for cannabis companies to venture into as many high-margin opportunities as possible. As the recreational market risks suffering from a supply glut in a few years’ time — which will drag down margins within the recreational segment — there is a variety of other avenues pot firms can follow. While Canopy focuses mainly on the recreational market, its margins are second best to those of Aurora.

During its latest reported quarter, Canopy recorded a gross margin “before fair value impacts in cost of sales” of just 16%. Its rival reported a gross margin “before fair-value adjustments on consumer cannabis revenue” of 50%. Even when computing these metrics in the traditional way, Aurora still reported a gross margin of 80% compared to 73% for Canopy.

Net losses

Neither company is consistently profitable yet. However, Canopy’s net loss of $0.98 per share ($335,607,000) was a 216% decrease year over year; the company attributed this significant decline to operating expenses on facilities that aren’t in service yet. The bill wasn’t as bad for Aurora, which recorded a net loss of about $158,354,000. However, much of this loss was due to a significant non-cash adjustment on convertible notes it issued in January due to its stock price rising.

Looking forward

Canopy still occupies the throne in the Canadian cannabis market, as its closest competitor does not come close to matching its sales and revenue figures. However, the firm reported a significant loss this quarter, and its share price may be a bit of a turn off for many investors. Aurora does offer higher gross margins and seems closer to being consistently profitable; the Edmonton-based pot company is also projected to have a higher production capacity than all of its competitors. Both companies have their respective strengths and weaknesses, but Canopy probably posted a slightly stronger overall performance this time around. 

You might be missing out on one of the biggest opportunities in Canadian investing history…

Marijuana was legalized across Canada on October 17th, and a little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

Besides making key partnerships with Facebook and Amazon, they’ve just made a game-changing deal with the Ontario government.

One grassroots Canadian company has already begun introducing this technology to the market – which is why legendary Canadian investor Iain Butler thinks they have a leg up on Amazon in this once-in-a-generation tech race.

This is the company we think you should strongly consider having in your portfolio if you want to position yourself wisely for the coming marijuana boom.

Learn More About This TSX Stock Now

More reading

Fool contributor Prosper Bakiny owns shares of Aurora Cannabis.

Source: The Fool
Aurora Cannabis (TSX:ACB) vs. Canopy Growth (TSX:WEED): Which Company Had the Better Quarter?
The Fool

The Motley Fool
Contributor for investorsnews.ca
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related posts